Frontier Investment Management’s Perspective Therapeutics CATX Stock Holding History

Frontier Investment Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$10K	Hold	1,800	–	–	﹤0.01%	278
2020 Q1	$10K	Hold	1,800	–	–	﹤0.01%	261
2019 Q4	$11K	Hold	1,800	–	–	﹤0.01%	325
2019 Q3	$6K	Hold	1,800	–	–	﹤0.01%	289
2019 Q2	$7K	Hold	1,800	–	–	﹤0.01%	267
2019 Q1	$7K	Buy	1,800 +600	+50%	+$2.34K	﹤0.01%	256
2018 Q4	$4K	Buy	+1,200	New	+$5.14K	﹤0.01%	247

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HPWM

Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CWM

Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Frontier Investment Management's CATX Position: Q2 2020 in Review

Frontier Investment Management held its Perspective Therapeutics (CATX) position steady in Q2 2020 at 1,800 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Frontier Investment Management first reported a position in CATX in Q4 2018 and has held it in 7 quarters since. The position peaked at $11K in Q4 2019. 38 funds tracked by Wall St. Rank hold CATX as of Q2 2020.

Frontier Investment Management held 1,800 shares of Perspective Therapeutics worth $10K as of Q2 2020.
Frontier Investment Management left its Perspective Therapeutics share count unchanged in Q2 2020.
Perspective Therapeutics made up ﹤0.01% of Frontier Investment Management's portfolio in Q2 2020, its #278 holding.
Frontier Investment Management first reported a position in Perspective Therapeutics in Q4 2018 and has held it in 7 quarters since.
Frontier Investment Management's Perspective Therapeutics position peaked at $11K in Q4 2019.
38 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.